Lv M - Search Results

1

Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.

Chen F, Gao S, Wang F, Ma J, Zhang M, Lv M, Zhou Q, Fu Z, Lu C, Yin H. Chen F, et al. Among authors: lv m. Tumour Biol. 2016 Mar;37(3):3365-70. doi: 10.1007/s13277-015-4173-9. Epub 2015 Oct 7. Tumour Biol. 2016. PMID: 26446459

2

Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.

Lv J, Fu Z, Shi M, Xia K, Ji C, Xu P, Lv M, Pan B, Dai L, Xie H. Lv J, et al. Among authors: lv m. Biomed Pharmacother. 2015 Feb;69:162-9. doi: 10.1016/j.biopha.2014.11.028. Epub 2014 Nov 25. Biomed Pharmacother. 2015. PMID: 25661353

3

Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women.

Xu N, Wang F, Lv M, Cheng L. Xu N, et al. Among authors: lv m. Biomed Pharmacother. 2015 Feb;69:221-7. doi: 10.1016/j.biopha.2014.12.002. Epub 2014 Dec 12. Biomed Pharmacother. 2015. PMID: 25661361

4

Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.

Xu N, Chen F, Wang F, Lu X, Wang X, Lv M, Lu C. Xu N, et al. Among authors: lv m. Tumour Biol. 2015 Sep;36(10):7659-65. doi: 10.1007/s13277-015-3469-0. Epub 2015 May 1. Tumour Biol. 2015. PMID: 25929808

5

Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.

Xu P, Wang L, Huang L, Li W, Lv S, Lv M, Ma J, Zhou Q, Wu X, Fu Z, Lu C, Yin H. Xu P, et al. Among authors: lv m, lv s. Biomed Pharmacother. 2015 Oct;75:173-8. doi: 10.1016/j.biopha.2015.07.019. Epub 2015 Aug 17. Biomed Pharmacother. 2015. PMID: 26293775

6

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer.

Lv M, Xu P, Wu Y, Huang L, Li W, Lv S, Wu X, Zeng X, Shen R, Jia X, Yin Y, Gu Y, Yuan H, Xie H, Fu Z. Lv M, et al. Among authors: lv s. Oncotarget. 2016 Mar 15;7(11):13047-59. doi: 10.18632/oncotarget.7509. Oncotarget. 2016. PMID: 26910840 Free PMC article.

7

Distinct expression profile of lncRNA in endometrial carcinoma.

Xu J, Qian Y, Ye M, Fu Z, Jia X, Li W, Xu P, Lv M, Huang L, Wang L, Ruan H, Lv J. Xu J, et al. Among authors: lv m, lv j. Oncol Rep. 2016 Dec;36(6):3405-3412. doi: 10.3892/or.2016.5173. Epub 2016 Oct 14. Oncol Rep. 2016. PMID: 27748922

8

LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer.

Wang H, Fu Z, Dai C, Cao J, Liu X, Xu J, Lv M, Gu Y, Zhang J, Hua X, Jia G, Xu S, Jia X, Xu P. Wang H, et al. Among authors: lv m. Sci Rep. 2016 Dec 12;6:38983. doi: 10.1038/srep38983. Sci Rep. 2016. PMID: 27941916 Free PMC article.

9

Long noncoding RNAs (lncRNAs) in triple negative breast cancer.

Wang Q, Gao S, Li H, Lv M, Lu C. Wang Q, et al. Among authors: lv m. J Cell Physiol. 2017 Dec;232(12):3226-3233. doi: 10.1002/jcp.25830. Epub 2017 Feb 21. J Cell Physiol. 2017. PMID: 28138992 Review.

10

Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells.

Huang L, Zeng L, Chu J, Xu P, Lv M, Xu J, Wen J, Li W, Wang L, Wu X, Fu Z, Xie H, Wang S. Huang L, et al. Among authors: lv m. Mol Med Rep. 2018 Jul;18(1):243-253. doi: 10.3892/mmr.2018.8942. Epub 2018 Apr 27. Mol Med Rep. 2018. PMID: 29749447 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,870 results

Search Page

Filters